Tzelepi, V., Efstathiou, E., Wen, S., Troncoso, P., Karlou, M., Pettaway, C. A., . . . Pagliaro, L. C. (2011). Persistent, Biologically Meaningful Prostate Cancer After 1 Year of Androgen Ablation and Docetaxel Treatment. American Society of Clinical Oncology.
Dyfyniad Arddull ChicagoTzelepi, Vassiliki, et al. Persistent, Biologically Meaningful Prostate Cancer After 1 Year of Androgen Ablation and Docetaxel Treatment. American Society of Clinical Oncology, 2011.
Dyfyniad MLATzelepi, Vassiliki, et al. Persistent, Biologically Meaningful Prostate Cancer After 1 Year of Androgen Ablation and Docetaxel Treatment. American Society of Clinical Oncology, 2011.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.